Stryker Stock News

DUBLIN--(BUSINESS WIRE)--The "Global Surgical Robots Market" report has been added to ResearchAndMarkets.com''s offering. The global surgical robots market was valued at $8052.67 Million in the year 2020 with North America region leading the regional market share. Companies Mentioned Intuitive Surgical Stryker Corporation Medtronic Smith & Nephew Zimmer Biomet Accuray Incorporated Renishaw Asensus Surgical Medrobotics Corporation Think Surgical The market is projected to display momentous gr

Riding The Stock Waves: Update On The Medical Devices Sector

Stryker Corporation with ticker code (SYK) have now 22 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 315 and 251 with the average target price sitting at 283.68. Now with the previous closing price of 251.58 this would indicate that there is a potential upside of 12.8%. The 50 day moving average now sits at 258.62 and the 200 day moving average is 261.79. The company has a market cap of $93,684m. Company Website: https://www.stryker.com [stock_market_widget type="chart" template="basic" color="green" assets=SYK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $105,637m based on the market concensus. Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.

WASHINGTON, Feb. 19, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research''s recent analysis of the Global ICU Beds Market finds that additional facilities that supplement the patient''s relief, is expediting market growth. Primarily driven by technological innovations in ICU Beds, the total global ICU Beds Market is estimated to reach USD 2,219.3 Million by 2028. The market stood at a revenue of USD 1,593.8 Million in the year 2021, and is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 5.1%. Furthermore, increasing number of beds in private hospitals, as volume of chronic care patients increases is also anticipated to augment the growth of the global ICU Beds Market, states Vantage Market Research, in a report, titled, "ICU Beds Market by Type (Full Electric Beds, Semi Electric Beds, Manual Beds), by Application (Traditional ICU, Pediatric ICU, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)".

New York, USA, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Global Orthobiologics Market is Anticipated to Grow at a CAGR of 4.44% During the Forecast Period (2021-26) | DelveInsight As per DelveInsight analysis, a growing geriatric population at risk of developing various bone degenerative disorders, an increase in traumatic injuries such as car accidents, sports injuries, and others are expected to boost the Orthobiologics market growth. Furthermore rising investments in R&D and collaborations by key manufacturers, as well as an increase in various orthobiologic product approvals will also drive the market. DelveInsight''s Orthobiologics Market Insights and Forecast report provides the current and forecast Orthobiologics market, upcoming developments in the medical devices, individual market shares, challenges, drivers, barriers, market growth trends, and key players in the Orthobiologics market. Some of the Key Highlights from the Orthobiologics Market Report According to DelveInsight analysis, North America is expected to dominate the overall Orthobiologics Market during the forecasted period.

The "Implantable Biomaterials Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. This report provides the strategists, marketers and senior management with the critical information they need to assess the global implantable biomaterials market. The global implantable biomaterials market is expected to grow from $103.9 billion in 2020 to $114.35 billion in 2021 at a compound annual growth rate (CAGR) of 10.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $161.22 billion in 2025 at a CAGR of 9%. Companies Mentioned Evonik Industries AG Royal DSM Zimmer Biomet Holdings Carpenter Technology Corporation Collagen Matrix Corbion BASF SE Invibio Ltd.

BAX vs. SYK: Which Stock Is the Better Value Option?

Kalamazoo, Michigan, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022.

Kalamazoo, Michigan, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Cowen 42 nd Annual Health Care Conference on Monday, March 7, 2022.

BAX vs. SYK: Which Stock Is the Better Value Option?

If any investor has stood the test of time, it is Warren Buffett, and with good reason.

Higher revenues, software strength, and broad-based growth ably supported by dynamic business fundamentals enable Vocera (VCRA) to beat fourth-quarter 2021 earnings estimates.

The research reports on "Regenerative Medicines Market" report give a detailed overview of the factors affecting the global scope of business. Information in the global Keyword market report provides forecast data for future market growth in global demand and supply.

With its strong business model, this healthcare stock is set for a strong future.

The Vanguard Health Care Fund (Trades, Portfolio) released its fourth-quarter 2021 portfolio earlier this week.